BioCentury | Sep 4, 2014
Distillery Therapeutics

Indication: Ophthalmic disease

...kDa (GJC1; CX45) In vitro and mouse studies suggest inhibiting gap junction components CX36 or CX45...
...death compared with vehicle. In mouse retinas, Cx36 knockout protected against NMDA-induced cell death and Cx45...
Items per page:
1 - 1 of 1